Ventyx Biosciences Inc. (VTYX)

1.45

-0.13 (-8.23%)

At close: Mar 03, 2025, 3:55 PM

Ventyx Biosciences Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Net Income	-135.12M	-192.96M	-108.43M	-83.75M	-28.17M	-4.33M
Depreciation & Amortization	1.35M	941K	470K	30K	n/a	n/a
Stock-Based Compensation	22.93M	28.59M	16.57M	2.73M	45K	198K
Other Working Capital	-7.92M	6.55M	-6.77M	1.57M	221K	230K
Other Non-Cash Items	-9.47M	-8.89M	-2.23M	38.32M	21.12M	896K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-10.56M	5.81M	-5.16M	4.02M	812K	591K
Operating Cash Flow	-130.87M	-166.52M	-98.77M	-38.65M	-6.2M	-2.64M
Capital Expenditures	-241K	-514K	-275K	-262K	n/a	n/a
Acquisitions	n/a	n/a	74.66K	1.9M	n/a	n/a
Purchase of Investments	-283.65M	-272.27M	-347.24M	-232.5M	n/a	n/a
Sales Maturities Of Investments	268.38M	373.73M	272.58M	16.5M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-74.66K	-216K	n/a	n/a
Investing Cash Flow	-15.51M	100.94M	-74.93M	-214.37M	n/a	n/a
Debt Repayment	n/a	n/a	n/a	450K	6.13M	2.95M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	27.07M	4.92M	2.37M	164.29M	2K	1K
Financial Cash Flow	122.11M	53.33M	167.77M	323.55M	6.13M	2.95M
Net Cash Flow	-24.32M	-12.27M	-5.97M	70.55M	-65K	309K
Free Cash Flow	-131.11M	-167.04M	-99.05M	-38.91M	-6.2M	-2.64M